Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPainchek Ltd

Painchek Ltd

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.07 AUD -0.00 ( 4.11%)
Last update at 2026-11-12T04:46:00Z
VOLUME
68517
Market Cap
14.65M

Momentum Score

…

PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.07
Low
0.07
High
52 Week Price Range
0.07
Low
0.48
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Painchek Ltd develops an automated pain-assessment platform using facial-recognition and AI to detect pain in non-verbal patients in aged-care and clinical settings. Long-term growth drivers include demographic aging, rising dementia prevalence, increased adoption of digital clinical tools and geographic expansion that could support recurring software revenues. The clinical focus and data-driven approach may appeal to investors seeking health-tech exposure in aged-care.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.07
Dividend Yield
-
Revenue TTM
3.74M
Revenue Per Share
0.02
Gross Profit TTM
2.64M
Debt / Equity
-2.97
ROE
-383.21%
Net Debt
-1.74M
ROCE
23470.75%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -10.06M -7.67M -8.31M -7.57M -5.72M
Net income -8.94M -7.67M -8.31M -7.57M -5.72M
Selling general administrative - 3.22M 3.40M 3.87M 3.05M
Selling and marketing expenses - 2.64M 2.05M 1.86M 1.66M
Gross profit 2.64M 1.00M 0.73M 0.71M -0.26M
Reconciled depreciation - - 0.03M 0.02M 0.01M
Ebit - -7.67M -9.51M -8.78M -7.60M
Ebitda -9.92M -7.65M -9.49M -8.76M -7.59M
Depreciation and amortization - 0.02M 0.03M 0.02M 0.01M
Operating income -9.92M -9.11M -9.51M -7.58M -5.73M
Other operating expenses 13.66M 12.47M 12.19M 9.53M 6.71M
Interest expense 0.20M - - - 0.02M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - - 0.01M 0.01M 0.02M
Net interest income - - 0.01M 0.01M 0.02M
Income tax expense -1.12M - -1.21M -0.02M -0.03M
Total revenue 3.74M 3.36M 2.67M 1.95M 0.98M
Total operating expenses 12.55M 10.11M 10.24M 9.49M 7.35M
Cost of revenue 1.10M 2.36M 1.95M 1.24M 1.24M
Total other income expense net -0.14M 1.44M 1.21M 1.18M 1.85M
Net income from continuing ops - - -8.31M -7.57M -5.72M
Net income applicable to common shares - -7.67M -8.31M -7.57M -5.72M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 7.63M 2.15M 4.18M 2.80M 6.65M
Other current assets 0.08M 0.07M 0.07M - -0.00M
Total liab 9.06M 3.26M 2.89M 2.13M 1.83M
Total stockholder equity -1.43M -1.11M 1.29M 0.67M 4.82M
Other current liab 2.59M 2.46M 1.14M 1.63M 1.55M
Common stock - 47.60M 43.39M 35.18M 32.48M
Capital stock - - - 35.18M 32.48M
Retained earnings -73.50M -64.56M -56.89M -48.58M -41.01M
Cash 5.99M 1.62M 3.56M 2.51M 6.14M
Cash and equivalents - - - 2.51M 6.14M
Total current liabilities 7.67M 3.26M 2.89M 2.13M 1.83M
Current deferred revenue - - 0.91M - -
Net debt -1.74M -1.62M -3.56M -2.51M -6.14M
Short term debt 4.25M - - 0.00M 0.00M
Short long term debt total 4.25M - - - -
Other stockholder equity 72.06M - - 14.07M 13.34M
Property plant equipment - - - 0.02M 0.03M
Total current assets 7.61M 2.13M 4.15M 2.77M 6.63M
Net tangible assets - - - 0.67M 4.82M
Net receivables 1.53M 0.45M 0.52M 0.20M 0.44M
Inventory - - 0.00M - 0.05M
Accounts payable 0.83M 0.80M 0.84M 0.50M 0.28M
Accumulated other comprehensive income - 15.84M 14.79M 14.07M 13.34M
Non currrent assets other - - - -0.02M -
Non current assets total 0.02M 0.02M 0.03M 0.02M 0.03M
Long term debt total - - - 0.00M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.03M -0.01M -0.02M
Change to liabilities - - - 0.18M -1.75M
Total cashflows from investing activities -0.01M -0.01M -0.03M -0.01M -0.02M
Total cash from financing activities 13.64M 4.82M 8.21M 2.70M 1.75M
Change to operating activities - - - 0.06M 0.03M
Net income -8.94M -7.67M -8.31M -7.57M -5.72M
Change in cash 4.38M -1.94M 1.05M -3.63M -5.28M
Begin period cash flow 1.62M 3.56M 2.51M 6.14M 11.42M
End period cash flow 5.99M 1.62M 3.56M 2.51M 6.14M
Total cash from operating activities -9.24M -6.75M -7.13M -6.32M -7.00M
Issuance of capital stock - - 8.67M 2.82M 1.94M
Depreciation - 0.02M 0.03M 0.02M 0.01M
Other cashflows from investing activities - - - 0.00M -
Change to account receivables -1.07M 0.03M -0.22M 0.24M -0.12M
Sale purchase of stock - 5.12M -0.46M -0.13M -0.20M
Other cashflows from financing activities - -0.31M -0.03M -0.01M -0.02M
Change to netincome - - - 0.77M 0.55M
Capital expenditures 0.01M 0.01M 0.03M 0.01M 0.02M
Change in working capital -0.93M 0.11M 0.44M 0.24M -0.12M
Stock based compensation - 0.47M 0.71M 0.77M 0.55M
Other non cash items 0.63M 0.32M 0.44M 1.24M -1.29M
Free cash flow -9.25M -6.77M -7.16M -6.34M -7.02M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PCK
Painchek Ltd		 -0.00
4.11%		 0.07 - - 3.91 8.81 3.34 -3.65
PME
Pro Medicus Ltd		 -4.52
2.18%		 202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.06
2.53%		 2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 0.12
3.30%		 3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -0.14
3.91%		 3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Painchek Ltd

PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

35 Lime Street, Sydney, NSW, Australia, 2000

61 4 2125 2123

https://www.painchek.com

Name Title Year Born
Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICD MD, CEO & Director NA
Mr. Iain McAdam Chief Financial Officer NA
Mr. Andrew Hoggan Mang. & Head of Operations NA
Mr. Scott Robertson M.B.A. Chief Technology Officer NA
Prof. Jeff Hughes Ph.D. Chief Scientific Officer NA
Mr. David Allsopp Head of Bus. Devel. ANZ NA
Mr. Pete Shergill Head of Bus. Devel. UK NA
Ms. Sally McDow Company Sec. NA
Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. MD, CEO & Director NA
Mr. Andrew Hoggan Manager & Head of Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…